Skip to content
Tiamat Sciences prepares vegetable protein for cheaper cellular meat production – TechCrunch

The cell growth medium is a component of cell farming that makes it possible to manufacture meat grown in the laboratory at a lower cost. However, the traditional methods of making these growth factors, or reactants, are themselves expensive, making it difficult to manufacture on a large scale.

On average, reports show that lab-grown meat costs around $ 50, but new technology could lower that price to a more reasonable $ 3 per pound by 2030.

Tiamat Sciences is a biotechnology startup developing a more profitable biomolecule aimed at replacing more expensive bioreactors. Today, she announced $ 3 million in seed funding, led by True Ventures, with participation from Social Impact Capital and Cantos.

Tiamat Sciences prepares vegetable protein for cheaper cellular meat production – TechCrunch

France-Emmanuelle Adil, Founder and CEO, Tiamet Sciences. Image credits: Tiamet Sciences

Company CEO France-Emmanuelle Adil founded the company in 2019 to make animal-free protein using a proprietary plant molecular farming approach that combines biotechnology, vertical farming, and computer design to reinvent proteins. recombinant.

“Growth factors used in the media are expensive right now,” she told TechCrunch. “We can significantly reduce costs and achieve price parity with meat. “

Adil estimates that today’s growth factor costs $ 2 million per gram to manufacture, but she believes that with the efforts of Tiamat Sciences and others, that cost could be multiplied by 10 with a focus on making it 1,000 times cheaper by 2025 so that large-scale production can proceed.

Ahead of the $ 3 million round of funding, the company launched a small round last July to give it total funding of $ 3.4 million to date. Adil wanted to expand the business, which was in Belgium, where it has an operating site, and moved to North Carolina in May.

The new funding will help build a pilot production facility in Durham, North Carolina, and technology development. The company is already on the way to achieving carbon neutral production.

She has yet to be able to disclose customers, but said the company is in the process of developing its first product, which is slated for release by the end of the year. Tiamet would then send samples to customers for testing, which she says will lead to some partnerships in 2022.

In addition to food, Adil says Tiamat’s approach could be applicable in other industries like regenerative medicine and vaccine production.

“The growth factors are transferable to other industries because the processes are similar,” she added. “We will be working on the expansion for the end of 2022. We will scale very quickly with a number of factories, then 100,000 factories. We are in discussions with companies to help us grow, but gradually. “

Phil Black, co-founder of True Ventures, said investing in Tiamat Sciences is part of his herbal portfolio. The initial money raised by the company allows them to prove to people that their technology works and to produce it for testing. Then there will be a much larger cycle to go from liters to gallons.

“The cellular meat industry is here to stay and now people are interested in making it more profitable for themselves and getting more out of it,” he added. “There are limited factors and Taimat’s solution will be a game changer. “

Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.